LFSCvsPSCHETF Comparison
VS
F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. LFSC's top 3 sector exposures are Healthcare and Sovereign. In contrast, PSCH's top sector exposures are Healthcare LFSC is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.29% for PSCH. LFSC is up 23.23% year-to-date (YTD) with +$8M in YTD flows. PSCH performs worse with 20.24% YTD performance, and -$10M in YTD flows. Run a side-by-side ETF comparison of LFSC and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
LFSC vs PSCH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LFSC PSCH | +4.17%+5.27% | +20.39%+19.02% | +23.23%+20.24% | +82.30%+36.79% | n/a+19.78% | n/a-15.14% |
| Flows | LFSC PSCH | +$2M+$6M | +$3M+$9M | +$8M-$10M | +$17M-$13M | --$133M | --$230M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LFSC PSCH | +26.23%+17.29% | +26.91%+20.07% | n/a+21.86% | n/a+22.90% |
| Max drawdown | LFSC PSCH | -6.53%-2.96% | -16.25%-15.36% | n/a-22.80% | n/a-46.32% |
| Max drawdown duration | LFSC PSCH | 20d17d | 168d168d | n/a488d | n/a1786d |
Trading data
LFSC | PSCH | |
Last sale 7/27/2026 at 5:45 PM | $45.30 | $53.16 |
| Previous close 07/24/2026 | $45.10 | $52.95 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
LFSC
is actively managed and doesn’t replicate an indexLFSC | PSCH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/27/2026 at 5:45 PM
Live
Closed
LFSC | PSCH | |
|---|---|---|
| Last price | $45.30 | $53.16 |
| 1D performance | +0.44% | +0.40% |
| AuM | $123.48 M | $162.74 M |
| E/R | 0.79% | 0.29% |
Characteristics
LFSC | PSCH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Emerald Group | Invesco |
| Benchmark | - | S&P SmallCap 600 Capped Health Care Index |
| N° of holdings | 40 | 75 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 31, 2024 | April 7, 2010 |
| ESG | No | No |
Advertisement
Exposure
Countries
LFSC
USA
90.9%
United Kingdom
7.04%
Other
2.06%
PSCH
USA
95.33%
Other
4.67%
Sectors
LFSC
Healthcare
98.03%
Other
1.97%
PSCH
Healthcare
100%
Other
0%
Advertisement
Diversification
LFSC
Total weight of top 15 holdings out of 15
73.24%
PSCH
Total weight of top 15 holdings out of 15
49.48%
Top 15 holdings
Data as of June 30, 2026
LFSC
Travere Therapeutics, Inc.
8.37%
Cogent Biosciences, Inc.
7.18%
LivaNova Plc
7.04%
Spyre Therapeutics, Inc.
6.71%
Guardant Health, Inc.
5.56%
Corcept Therapeutics, Inc.
5.27%
Mirum Pharmaceuticals, Inc.
5.25%
BillionToOne, Inc.
4.25%
Cytokinetics, Inc.
4.13%
Veradermics, Inc.
3.76%
United Therapeutics Corp.
3.55%
Trevi Therapeutics, Inc.
3.50%
Savara, Inc.
3.20%
Dianthus Therapeutics, Inc.
2.77%
Nektar Therapeutics
2.70%
PSCH
Molina Healthcare, Inc.
5.29%
BrightSpring Health Services, Inc.
4.82%
Krystal Biotech, Inc.
4.32%
Alkermes Plc
4.06%
Glaukos Corp.
3.75%
Corcept Therapeutics, Inc.
3.69%
Protagonist Therapeutics, Inc.
3.26%
TG Therapeutics, Inc.
3.25%
PTC Therapeutics, Inc.
3.10%
Ligand Pharmaceuticals, Inc.
2.69%
Teleflex, Inc.
2.54%
Liquidia Corp.
2.43%
Indivior Pharmaceuticals, Inc.
2.25%
Veracyte, Inc.
2.13%
RadNet, Inc.
1.90%
Frequently asked questions about LFSC and PSCH
How have the LFSC and PSCH ETFs performed in 2026?
As of July 24, 2026, LFSC is up 23.23% year-to-date (YTD), while PSCH has returned 20.24%. That puts LFSC better performer ahead so far this year.
Which ETF is attracting more investor money: LFSC or PSCH?
Year-to-date, the LFSC ETF saw +$8M in flows, compared to -$10M for PSCH.
Which ETF is more volatile: LFSC or PSCH?
Over the past year, LFSC had a volatility of 26.91%, while PSCH experienced 20.07%.
Which ETF is bigger: LFSC or PSCH?
As of July 24, 2026, LFSC holds $123.48 M in assets under management (AUM), while PSCH manages $162.74 M.
What sectors do the LFSC and PSCH ETFs invest in?
LFSC leans toward sectors like Healthcare. Meanwhile, PSCH focuses on Healthcare.
What are the top holdings of the LFSC ETF and PSCH ETF?
LFSC top holdings include Travere Therapeutics, Inc., Cogent Biosciences, Inc. and LivaNova Plc. PSCH holds in its top three: Molina Healthcare, Inc., BrightSpring Health Services, Inc. and Krystal Biotech, Inc..
Which ETF is more diversified: LFSC or PSCH?
LFSC holds 40 securities with 73.24% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 49.48%.
Advertisement
Advertisement
